YOU WILL GET ALL THE FACTS

New Post Public Reply Private Reply Replies (1) Message Board
gator11
459
YOU WILL GET ALL THE FACTS !

http://cincominas.com/

http://www.minerasanjorge.com/


Sooah Monday, 04/22/13 02:50:59 PM
Re: None 0
Post # of 167679
THE MYSTERY BUYER BEHIND HUNDREDS OF MILLIONS OF SHARES POST SUSPENSION

This is speculation on my part but the mystery buyer here is none other than SRGE itself and here is why.

Contrary to the opinions of some, the 'Mexicans' including 'Novamex' cannot just take the assets back. The assets must be purchased for a consideration. The problem here is that Novamex is 'stuck' because last year, it converted a big portion of its equity holdings in SRGE to debt. Novamex was/is a beneficial owner and a creditor. Being a creditor in this situation does not help Novamex because under an asset purchase agreement, the buyer does not have to assume debts associated with the assets being purchased. If MSJ assumed the Novamex debt, they'd have to pay for it in cash. The challenge this leaves for Novamex and MSJ is that Novamex would lose out on 200 million shares of its investment and MSJ would have to come up with the cash. Another challenge is that there is no rule that would force SRGE to pay down the Novamex liability either.

The best way to handle this is for SRGE to buy up all shares in the open market and allow Novamex to exercise its option to re-convert debt to equity, hence extinguishing all debt owed to Novamex. This conversion is totally possible because past transactions involving Novamex were effected at 0.00625 per share, hence if SRGE bought up all shares at 0.00625 or less like 0.001 or 0.0005, a same or better condition swap can occur.

MSJ can then purchase Cinco and other properties in an all stock deal. MSJ's stocks for SRGE's stocks.




Southridge Enterprises Inc. (SRGE) Stock Research Links

SRGE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading